Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
|
US |
|
T
|
Tao Heung Holdings Ltd
HKEX:573
|
HK |
|
SCSK Corp
TSE:9719
|
JP |
|
S
|
Sufrin Holdings Ltd
TASE:SFRN
|
IL |
|
Monex Group Inc
TSE:8698
|
JP |
|
I
|
ITH Corp
TWSE:6962
|
KY |
|
Autobio Diagnostics Co Ltd
SSE:603658
|
CN |
|
R
|
Riddhi Siddhi Gluco Biols Ltd
BSE:524480
|
IN |
|
P
|
Pne Pcb Bhd
KLSE:PNEPCB
|
MY |
|
S
|
SonHa International Corp
VN:SHI
|
VN |
|
Z
|
Ze Pak Sa
WSE:ZEP
|
PL |
|
Westlife Foodworld Ltd
BSE:505533
|
IN |
|
L
|
Lotte Chemical Titan Holding Bhd
KLSE:LCTITAN
|
MY |
|
QuickLogic Corp
NASDAQ:QUIK
|
US |
|
G
|
Ganso Co Ltd
SSE:603886
|
CN |
|
A
|
Adtraction Group AB
STO:ADTR
|
SE |
|
Helport AI Ltd
NASDAQ:HPAI
|
SG |
|
U
|
Unicommerce eSolutions Ltd
NSE:UNIECOM
|
IN |
|
H
|
Hwaxin Environmental Co Ltd
SZSE:301265
|
CN |
|
Sandesh Ltd
NSE:SANDESH
|
IN |
|
J
|
JiangXi Tianxin Pharmaceutical Co Ltd
SSE:603235
|
CN |
|
Y
|
Yinson Holdings Bhd
KLSE:YINSON
|
MY |
|
Aeria Inc
TSE:3758
|
JP |
|
Boab Metals Ltd
ASX:BML
|
AU |
Multiples-Based Value
The
Multiples-Based Value for
Ironwood Pharmaceuticals Inc (IRWD)
under the Base Case is
hidden
USD.
Compared with the current market price of 3.54 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
IRWD Competitors Multiples
Ironwood Pharmaceuticals Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
|
577.2m USD | 1.9 | 24 | 6.2 | 6.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 87.1 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5 | 23.9 | 13.9 | 13.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.2 | 27.9 | 21 | 21.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |